Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Interest & Investment Income (2016 - 2019)

Dexcom (DXCM) has disclosed Interest & Investment Income for 7 consecutive years, with $6.9 million as the latest value for Q1 2019.

  • On a quarterly basis, Interest & Investment Income rose 68.29% to $6.9 million in Q1 2019 year-over-year; TTM through Mar 2019 was $5.2 million, a 50.94% decrease, with the full-year FY2018 number at $2.4 million, down 64.18% from a year prior.
  • Interest & Investment Income was $6.9 million for Q1 2019 at Dexcom, up from -$3.8 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $6.9 million in Q1 2019 to a low of -$3.8 million in Q4 2018.
  • A 4-year average of $1.2 million and a median of $200000.0 in 2017 define the central range for Interest & Investment Income.
  • Biggest YoY gain for Interest & Investment Income was 1950.0% in 2018; the steepest drop was 180.0% in 2018.
  • Dexcom's Interest & Investment Income stood at -$600000.0 in 2016, then surged by 900.0% to $4.8 million in 2017, then plummeted by 179.17% to -$3.8 million in 2018, then surged by 281.58% to $6.9 million in 2019.
  • Per Business Quant, the three most recent readings for DXCM's Interest & Investment Income are $6.9 million (Q1 2019), -$3.8 million (Q4 2018), and $2.5 million (Q3 2018).